Search

Your search keyword '"Blackhall, Fiona H"' showing total 187 results

Search Constraints

Start Over You searched for: Author "Blackhall, Fiona H" Remove constraint Author: "Blackhall, Fiona H"
187 results on '"Blackhall, Fiona H"'

Search Results

1. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx

2. The evolution of non-small cell lung cancer metastases in TRACERx

3. The evolution of lung cancer and impact of subclonal selection in TRACERx

7. Body composition and lung cancer-associated cachexia in TRACERx

8. The evolution of lung cancer and impact of subclonal selection in TRACERx

9. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

24. Abstract 3810: Persistence of smoking signature 4 in the non-small cell lung cancer genome

28. Cough in Patients With Lung Cancer:A Longitudinal Observational Study of Characterization and Clinical Associations

31. Vasculogenic mimicry in small cell lung cancer

32. Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014

33. Abstract 3371: Genetic, phenotypic and functional characterisation of vasculogenic mimicry in small-cell lung cancer

34. Abstract CT117: Evaluation of the effect of crizotinib (CRZ) on the QT interval in patients with ALK-positive non-small cell lung cancer (NSCLC)

35. Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value

36. Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project

41. Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

42. Is Serum or Plasma More Appropriate for Intersubject Comparisons in Metabolomic Studies? An Assessment in Patients with Small-Cell Lung Cancer

43. Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

44. Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial

46. Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

47. Identification and functional analysis of SKA2 interaction with the glucocorticoid receptor

48. Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

Catalog

Books, media, physical & digital resources